Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

54%

7 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

6(50.0%)

N/A

4(33.3%)

Phase 2

1(8.3%)

Phase 3

1(8.3%)

12Total

Phase 4(6)

N/A(4)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT07292909Phase 4Recruiting

Effect of Empagliflozin on Inflammation

Role: lead

NCT06956846Phase 4Not Yet Recruiting

Efficacy of Topical Insuline in Corneal Epithelial Healing Post PRK

Role: lead

NCT06917768Not ApplicableCompleted

Oral Corticosteroids' Role in Pediatric Obstructive Sleep Apnea

Role: lead

NCT05924737Not ApplicableCompleted

Delta Waves and Cognitive Recovery

Role: collaborator

NCT05924659Not ApplicableRecruiting

Neurofeedback Training's Efficiency for Attentionnal Performances

Role: collaborator

NCT01321216Completed

Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon

Role: collaborator

NCT03936205Phase 2Completed

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Role: lead

NCT03786172Not ApplicableUnknown

Efficacy of Smoking Cessation Intervention for Head and Neck Cancer Patients

Role: collaborator

NCT03578042Phase 4Unknown

Fixed-Free HTN Trial

Role: lead

NCT02125682Phase 4Completed

The HDL Particle Protection Study

Role: lead

NCT01315366Phase 3Completed

Hypovitaminosis D : A Link Between Bone/Mineral and Fat/Fuel Metabolism

Role: collaborator

NCT02261922Phase 4Unknown

Ticagrelor and Endothelial Function

Role: lead

NCT01008345Phase 4Completed

Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol

Role: lead

All 13 trials loaded